{"id":13210,"date":"2020-10-07T13:35:36","date_gmt":"2020-10-07T11:35:36","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=13210"},"modified":"2024-12-06T15:00:39","modified_gmt":"2024-12-06T14:00:39","slug":"prof-dr-heiner-wedemeyer","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-heiner-wedemeyer\/","title":{"rendered":"Prof. Dr. Heiner Wedemeyer"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/span><\/div>

Prof. Dr. Heiner Wedemeyer<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>

I have been working for many years on chronic viral infections of the liver, which can lead to liver cirrhosis and hepatocellular cancer. My team was able to demonstrate the importance of various immune cells such as T cells and natural killer cells (NK cells) for the control of hepatitis B, C and D. The findings are particularly important for the use and control of antiviral therapies. A special focus in RESIST will be studies on hepatitis D, which is the most severe hepatitis infection.<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Professor Wedemeyer about his scientific work<\/h1><\/div>